Griffin, James D.
Harvard Medical School,
United States
2025 Rank: 11819
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 429 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11819 | 13001 |
| Total Cites | 37745 | 41782 |
| H-index | 97 | 102 |
| Hm-index | 37 | 38 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 227 | 231 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 1519 | 1564 |
| Number of Single+First+Last Authored Papers | 242 | 242 |
| Total Cites to Single+First+Last Authored Papers | 18416 | 19732 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 28908 | 30847 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.35 |
| Self-Citation Percentage |
9.66%
|
|
Griffin, James D.
Harvard Medical School,
United States
2024 Rank: 11142
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 418 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 11142 | 12070 |
| Total Cites | 36777 | 40770 |
| H-index | 95 | 101 |
| Hm-index | 36 | 38 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 219 | 223 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 1478 | 1523 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 17939 | 19251 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 28108 | 30018 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
9.79%
|
|
Griffin, James D.
Harvard Medical School,
United States
2023 Rank: 10046
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 384 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10046 | 11033 |
| Total Cites | 35975 | 39965 |
| H-index | 94 | 99 |
| Hm-index | 36 | 38 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 218 | 222 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 1457 | 1502 |
| Number of Single+First+Last Authored Papers | 248 | 248 |
| Total Cites to Single+First+Last Authored Papers | 17642 | 18955 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 27406 | 29301 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
9.98%
|
|
Griffin, James D.
Harvard Medical School,
United States
2022 Rank: 8931
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 357 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8931 | 9912 |
| Total Cites | 34646 | 38532 |
| H-index | 93 | 98 |
| Hm-index | 36 | 38 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 216 | 220 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 1421 | 1465 |
| Number of Single+First+Last Authored Papers | 245 | 245 |
| Total Cites to Single+First+Last Authored Papers | 17049 | 18344 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26317 | 28144 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
10.09%
|
|
Griffin, James D.
Dana-Farber Cancer Institute,
United States
2021 Rank: 8589
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 340 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 8589 | 9523 |
| Total Cites | 33713 | 37538 |
| H-index | 91 | 97 |
| Hm-index | 36 | 37 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 210 | 214 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 1385 | 1427 |
| Number of Single+First+Last Authored Papers | 244 | 244 |
| Total Cites to Single+First+Last Authored Papers | 16631 | 17898 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25610 | 27414 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
10.19%
|
|
Griffin, James D.
Dana-Farber Cancer Institute,
United States
2020 Rank: 7652
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 292 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 7652 | 8458 |
| Total Cites | 32220 | 35943 |
| H-index | 89 | 95 |
| Hm-index | 36 | 37 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 209 | 213 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 1347 | 1388 |
| Number of Single+First+Last Authored Papers | 238 | 238 |
| Total Cites to Single+First+Last Authored Papers | 15946 | 17195 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 24347 | 26077 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.38 |
| Self-Citation Percentage |
10.36%
|
|